HCA Holdings, Inc. (NYSE:HCA)‘s stock had its “buy” rating restated by equities researchers at Cantor Fitzgerald in a note issued to investors on Tuesday. They currently have a $90.00 price objective on the stock. Cantor Fitzgerald’s target price points to a potential upside of 18.14% from the stock’s current price.

The analysts wrote, “3Q17 results. Although there were no changes to last week’s guidance, HCA announced an additional $2 billion stock repurchase authorization, bringing its total authorization at 10/31/17 to $2.150 billion. HCA reported 3Q17 EPS of $1.53 (vs. $1.56 FactSet consensus) and EBITDA of $1,966 million (vs. $1,972 million) before unusual costs associated with hurricanes Harvey and Irma that totaled $140 million ($0.24 per share) and a retrospective audit of the Texas Medicaid Waiver that cost $50 million ($0.08 per share).””

Several other analysts have also issued reports on the company. Mizuho reiterated a “buy” rating on shares of HCA Holdings in a report on Friday, October 20th. Robert W. Baird set a $86.00 price objective on HCA Holdings and gave the company a “buy” rating in a research note on Thursday, October 19th. Oppenheimer Holdings, Inc. restated a “buy” rating and issued a $90.00 price objective (down previously from $95.00) on shares of HCA Holdings in a research note on Thursday, October 19th. Bank of America Corporation dropped their price objective on HCA Holdings from $92.00 to $86.00 and set a “neutral” rating on the stock in a research note on Thursday, October 19th. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $90.00 price objective on shares of HCA Holdings in a research note on Thursday, October 19th. Two analysts have rated the stock with a sell rating, six have given a hold rating and sixteen have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $91.00.

Shares of HCA Holdings (NYSE HCA) traded down 0.95% on Tuesday, hitting $75.46. The company had a trading volume of 1,951,801 shares. The firm has a market capitalization of $27.26 billion, a P/E ratio of 10.12 and a beta of 0.62. The firm has a 50 day moving average of $77.75 and a 200-day moving average of $81.36. HCA Holdings has a 12-month low of $67.00 and a 12-month high of $91.03.

COPYRIGHT VIOLATION WARNING: “HCA Holdings, Inc. (HCA) Earns “Buy” Rating from Cantor Fitzgerald” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/10/31/hca-holdings-inc-hca-earns-buy-rating-from-cantor-fitzgerald.html.

In related news, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction that occurred on Tuesday, October 17th. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the sale, the insider now owns 12,476 shares of the company’s stock, valued at approximately $973,128. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold a total of 6,450 shares of company stock worth $511,163 in the last 90 days. Company insiders own 2.90% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of HCA. Vanguard Group Inc. raised its stake in shares of HCA Holdings by 0.7% during the second quarter. Vanguard Group Inc. now owns 19,718,250 shares of the company’s stock valued at $1,719,431,000 after acquiring an additional 141,258 shares during the last quarter. Glenview Capital Management LLC raised its stake in shares of HCA Holdings by 2.6% during the second quarter. Glenview Capital Management LLC now owns 14,899,289 shares of the company’s stock valued at $1,299,218,000 after acquiring an additional 384,024 shares during the last quarter. Longview Partners Guernsey LTD raised its stake in shares of HCA Holdings by 22.6% during the third quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock valued at $886,247,000 after acquiring an additional 2,053,701 shares during the last quarter. LSV Asset Management raised its stake in shares of HCA Holdings by 5.5% during the second quarter. LSV Asset Management now owns 3,907,939 shares of the company’s stock valued at $340,772,000 after acquiring an additional 203,290 shares during the last quarter. Finally, APG Asset Management N.V. raised its stake in shares of HCA Holdings by 141.4% during the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock valued at $272,467,000 after acquiring an additional 2,005,193 shares during the last quarter. Institutional investors and hedge funds own 74.65% of the company’s stock.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.